Pear Therapeutics- Warrants (01/12/2026) Long Term Debt

Pear Therapeutics- Warrants (01/12/2026) (PEARW) currently reports a long-term debt of $8.2M as of December 2022. In the prior-year period, the figure was $0. Use the charts on this page to explore Pear Therapeutics- Warrants (01/12/2026)'s long-term debt history and peer comparisons.

Pear Therapeutics- Warrants (01/12/2026)'s long-term debt changed from $0 to $8.2M (period ending December 2022). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Pear Therapeutics- Warrants (01/12/2026) reported $8.2M in long-term debt as of December 2022. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $8.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Pear Therapeutics- Warrants (01/12/2026), and consider following PEARW for alerts when major investors trade the stock.